[1] Cornejo-Juarez P, Vilar-Compte D, Perez-Jimenez C, et al. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis, 2015; 31, 31-4. doi:  10.1016/j.ijid.2014.12.022
[2] Abdel-Wahab F, Ghoneim M, Khashaba M, et al. Nosocomial infection surveillance in an Egyptian neonatal intensive care unit. J Hosp Infect, 2013; 83, 196-9. doi:  10.1016/j.jhin.2012.10.017
[3] Li Y, Gong Z, Lu Y, et al. Impact of nosocomial infections surveillance on nosocomial infection rates:A systematic review. Int J Surg, 2017; 42, 164-9. doi:  10.1016/j.ijsu.2017.04.065
[4] Ebnother C, Tanner B, Schmid F, et al. Impact of an infection control program on the prevalence of nosocomial infections at a tertiary care center in Switzerland. Infect Control Hosp Epidemiol, 2008; 29, 38-43. doi:  10.1086/524330
[5] Bouassida K, Jaidane M, Bouallegue O, et al. Nosocomial urinary tract infections caused by extended-spectrum beta-lactamase uropathogens:Prevalence, pathogens, risk factors, and strategies for infection control. Can Urol Assoc J, 2016; 10, E87-93. doi:  10.5489/cuaj.3223
[6] Zhang L, Pang Y, Yu X, et al. Risk factors for pulmonary cavitation in tuberculosis patients from China. Emerg Microbes Infect, 2016; 5, e110. doi:  10.1038/emi.2016.111
[7] World Health Organization. Prevention of hospital-acquired infections:a practical guide. Geneva:World Health Organization, 2002. http://www.who.int/iris/handle/10665/67350
[8] De Angelis G, Cataldo MA, De Waure C, et al. Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients:a systematic review and meta-analysis. J Antimicrob Chemother, 2014; 69, 1185-92. doi:  10.1093/jac/dkt525
[9] Erdem H, Inan A, Altindis S, et al. Surveillance, control and management of infections in intensive care units in Southern Europe, Turkey and Iran——a prospective multicenter point prevalence study. J Infect, 2014; 68, 131-40. doi:  10.1016/j.jinf.2013.11.001
[10] Pang Y, Zhang Z, Wang Y, et al. Genotyping and Prevalence of Pyrazinamide-and Moxifloxacin-Resistant Tuberculosis in China, 2000 to 2010. Antimicrob Agents Chemother, 2017; 61, e02170-16. http://aac.asm.org/content/61/2/e02170-16.short
[11] Li YM, Tong XL, Xu HT, et al. Prevalence and Antimicrobial Susceptibility of Mycobacterium abscessus in a General Hospital, China. Biomed Environ Sci, 2016; 29, 85-90. http://d.wanfangdata.com.cn/Periodical/zhcmj201310015
[12] Vandenesch F, Lina G, Henry T. Staphylococcus aureus hemolysins, bi-component leukocidins, and cytolytic peptides:a redundant arsenal of membrane-damaging virulence factors? Front Cell Infect Microbiol, 2012; 2, 12. https://core.ac.uk/display/49661616
[13] Lausch KR, Fuursted K, Larsen CS, et al. Colonisation with multi-resistant Enterobacteriaceae in hospitalised Danish patients with a history of recent travel:a cross-sectional study. Travel Med Infect Dis, 2013; 11, 320-3. doi:  10.1016/j.tmaid.2013.06.004